Related Experiment Video
Updated: Apr 21, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Trends in pre-pregnancy diabetes among deliveries in 19 U.S. states, 2000-2010
Barbara H Bardenheier1, Giuseppina Imperatore1, Heather M Devlin1
1Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, Georgia.
Insights
Pre-pregnancy diabetes mellitus (PDM) deliveries rose significantly nationwide between 2000 and 2010, especially among women with hypertension. These trends highlight the need for improved diabetes prevention and control strategies for women of childbearing age.
Area of Science:
- Reproductive Health
- Maternal Health
- Endocrinology
Background:
- State-level data on pre-pregnancy diabetes mellitus (PDM) prevalence during delivery hospitalizations are crucial for healthcare planning.
- Understanding PDM trends informs public health interventions and healthcare delivery strategies.
Purpose of the Study:
- To analyze trends in PDM prevalence across various demographics (age, race/ethnicity, payer) and comorbidities (pre-eclampsia, hypertension) over an 11-year period.
- To quantify changes in PDM prevalence and associated conditions.
Main Methods:
- Utilized State Inpatient Databases from 2000-2010 to identify deliveries with PDM and comorbidities.
- Employed diagnosis-related group codes and ICD-9-CM codes for case identification.
- Applied general linear regression with a log-link and binomial distribution to assess annual changes.
Main Results:
- PDM deliveries increased significantly across all age groups, racial/ethnic groups, and states (p<0.01).
- Age-standardized PDM prevalence rose from 0.65 to 0.89 per 100 deliveries (37% relative increase, p<0.01).
- Proportion of PDM deliveries with pre-pregnancy hypertension increased from 7.4% to 14.1% (p<0.01).
Conclusions:
- Significant increases in PDM deliveries, particularly those with hypertension, necessitate targeted interventions.
- Effective diabetes prevention and control for women of childbearing age are vital for maternal and infant health outcomes.
Background:
Trends in state-level prevalence of pre-pregnancy diabetes mellitus (PDM; i.e., type 1 or type 2 diabetes diagnosed before pregnancy) among delivery hospitalizations are needed to inform healthcare delivery planning and prevention programs.
Purpose:
To examine PDM trends overall, by age group, race/ethnicity, primary payer, and with comorbidities such as pre-eclampsia and pre-pregnancy hypertension, and to report changes in prevalence over 11 years.
Methods:
In 2014, State Inpatient Databases from the Agency for Healthcare Research and Quality were analyzed to identify deliveries with PDM and comorbidities using diagnosis-related group codes and ICD-9-CM codes. General linear regression with a log-link and binomial distribution was used to assess the annual change.
Results:
Between 2000 and 2010, PDM deliveries increased significantly in all age groups, all race/ethnicity groups, and in all states examined (p<0.01). The age-standardized prevalence of PDM increased from 0.65 per 100 deliveries in 2000 to 0.89 per 100 deliveries in 2010, with a relative change of 37% (p<0.01). Although PDM rates were highest in the South, some of the largest relative increases occurred in five Western states (≥69%). Non-Hispanic blacks had the highest PDM rates and the highest absolute increase (0.26 per 100 deliveries). From 2000 to 2010, the proportion of PDM deliveries with pre-pregnancy hypertension increased significantly (p<0.01) from 7.4% to 14.1%.
Conclusions:
PDM deliveries are increasing overall and particularly among those with PDM who have hypertension. Effective diabetes prevention and control strategies for women of childbearing age may help protect their health and that of their newborns.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Introduction
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type II Diabetes I: Introduction
Hyperglycemia

